CSOs challenge DG’s third way as USTR discusses TRIPS waiver

The temporary TRIPS waiver seeks to suspend the implementation of several provisions in the TRIPS Agreement relating to copyrights, industrial designs, patents, and protection of undisclosed information for ramping up global production of diagnostics, medicines and vaccines in order to fight the worsening COVID-19 pandemic.